Belén Fernández-Puntero

Belén Fernández-Puntero

Auto-generated profile, based on publicly available information

Belén Fernández-Puntero

Clinical Analysis Service Hospital Universitario de La Paz Madrid Spain

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2026 in Nursing in Critical Care
Verified
Journal Article
Open access
PFPatricia Morales Fernández
Patricia Morales Fernández
FOFrancisco Javier Castro Olmo
Francisco Javier Castro Olmo
SGSara González‐Martín
Sara González‐Martín
MHMiguel Serrano Hernández
Miguel Serrano Hernández
MQManuel Quintana-Díaz
Manuel Quintana-Díaz
BFBelén Fernández‐Puntero
Belén Fernández‐Puntero
Background: The critically ill patient requires multiple extractions through catheters, implying a substantial blood loss. The discard method continues to be a commonly used method in Intensive Care Units. However, there is no homogeneity in practice. Aim: Determine the minimum blood discard volume to obtain samples through radial arterial catheter. Study Design: Quasi‐experimental, prospective, cross‐sectional study employing the STOBE checklist. Four consecutive arterial blood gases were performed considering the flush volume (sample A with 1 dead space discarding 1 mL, sample B with 2 discard space [2 mL], sample C with 3 discard space [3 mL] and control with 4 discard space [4 mL]). The study was approved by the Ethics and Pharmacological Research Committee of the Research Institute of La paz Hospital (Law No. 2023.564). It was conducted in the Burn Intensive Care Unit and the Resuscitation and Critical Care Unit of La Paz Hospital from September 2023 to June 2024. Results: We found values outside the Clinical Acceptance Interval (CAI) in sample A versus control in pCO 2 (47.42%), HCO 3 − (60.71%), Haemoglobin (67.85%), Na 2+ (7.14%), K + (71.42%) and glycaemia (21.42%). In the case of lactate, no values outside the Clinical Acceptance Interval were found. When comparing sample B versus control, we found significant differences in HCO 3 − ( p = 0.027) and glycaemia ( p = 0.001). However, none of the parameters studied presented values outside the Clinical Acceptance Interval. When the results were related to the Reference Value of Change (RVC), the pCO 2 and Haemoglobin values presented 3.57% of values outside the Clinical Acceptance Interval, respectively, although they did not present statistically significant differences ( p > 0.05). When comparing sample C versus control, no significant differences were found in any parameter, nor values outside the Clinical Acceptance Interval. Conclusions: The volume of discard required to obtain valid values is twice the volume used to purge the arterial catheterization system (2 mL) for obtaining samples for clinical use. Relevance to Clinical Practice: The calculation of the minimum amount of discard in the collection of blood samples through the arterial catheter is an intervention at no extra cost that will reduce iatrogenic anaemia, reducing the need for transfusions, the complications associated with this therapy and the reduction of costs in critically ill patients.

8 March 2024 in Burns
Verified
Journal Article
Closed access
EFEva Flores
Eva Flores
BEBelén Estébanez
Belén Estébanez
MQManuel Quintana-Díaz
Manuel Quintana-Díaz
BFBelén Fernández-Puntero
Belén Fernández-Puntero
KNKapil Nanwani
Kapil Nanwani
MSManuel Sánchez-Sanchez
Manuel Sánchez-Sanchez

1 January 2026 in Journal of Mass Spectrometry and Advances in the Clinical Lab
Verified
Journal Article
Open access
PDF file
MSMariana Serres-Gómez
Mariana Serres-Gómez
MSMª Gemma Serrano
Mª Gemma Serrano
MCMARIA LUISA GONZALEZ CASAUS
MARIA LUISA GONZALEZ CASAUS
BFBelén Fernández-Puntero
Belén Fernández-Puntero
PFPilar Fernández-Calle
Pilar Fernández-Calle
ASAntonio Buño Soto
Antonio Buño Soto
INTRODUCTION: Therapeutic drug monitoring (TDM) of immunosuppressive drugs is essential to maintain concentrations within narrow therapeutic windows and minimize toxicity. Automated LC–MS/MS platforms can combine the analytical specificity of mass spectrometry with workflow efficiency suitable for routine laboratories. OBJECTIVES: To preliminarily evaluate the analytical performance of the Cobas i601 automated LC–MS/MS system for quantifying tacrolimus, cyclosporine, everolimus, and sirolimus and to compare results with routine immunoassays and an LC–MS/MS method for sirolimus. METHODS: Imprecision, bias, and linearity were assessed according to the Clinical Laboratory Standards Institute (CLSI) EP10-A3 standard using quality-control materials. Method comparison and bias estimation versus the Dimension EXL 200 immunoassays and an LC–MS/MS technique for sirolimus followed the CLSI EP09-A3 standard. Regression analyses and predicted biases at therapeutic range concentrations were compared with allowable limits. RESULTS: The Cobas i601 showed good precision and linearity, meeting manufacturer specifications. The highest coefficients of variations for tacrolimus, everolimus, cyclosporine, and sirolimus were 4.0%, 4.7%, 3.6%, and 4.8%, and the maximum EP10-A3 biases were −7.4%, −3.9%, 4.7%, and 5.4%, respectively. In the method comparison, tacrolimus, everolimus, and cyclosporine showed substantial negative biases versus immunoassays (−22.7%, −38.9%, and −37.5%), exceeding allowable limits. Sirolimus exhibited smaller positive bias relative to the LC–MS/MS method (12.5%). Interchangeability between the methodologies cannot be assumed. CONCLUSION: The Cobas i601 provides reliable automated LC–MS/MS quantification of immunosuppressants, with good precision and linearity. Method-dependent biases highlight the need for careful interpretation during technology transitions. The Cobas i601 shows strong potential for routine LC–MS/MS implementation in TDM in clinical laboratories.